Total Payments
$1,858
2024 Payments
$305.29
Companies
25
Transactions
105
Medicare Patients
3,473
Medicare Billing
$370,360
Payment Breakdown by Category
Food & Beverage$1,858 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,858 | 105 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $696.36 | 38 | $0 (2024) |
| Gilead Sciences, Inc. | $342.28 | 16 | $0 (2022) |
| ABBVIE INC. | $266.92 | 17 | $0 (2024) |
| Boston Scientific Corporation | $54.66 | 2 | $0 (2020) |
| Janssen Biotech, Inc. | $42.66 | 3 | $0 (2024) |
| QOL Medical, LLC | $38.46 | 3 | $0 (2022) |
| Phathom Pharmaceuticals, Inc. | $33.65 | 2 | $0 (2024) |
| Synergy Pharmaceuticals Inc | $33.50 | 3 | $0 (2018) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $32.76 | 1 | $0 (2019) |
| RedHill Biopharma Inc. | $32.03 | 2 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $305.29 | 17 | ABBVIE INC. ($103.24) |
| 2023 | $300.26 | 16 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($215.01) |
| 2022 | $266.07 | 18 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($151.94) |
| 2021 | $202.35 | 11 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($115.61) |
| 2020 | $106.89 | 5 | Boston Scientific Corporation ($54.66) |
| 2019 | $192.55 | 10 | Gilead Sciences, Inc. ($67.23) |
| 2018 | $217.91 | 14 | Gilead Sciences, Inc. ($89.70) |
| 2017 | $266.63 | 14 | Gilead Sciences Inc ($150.34) |
All Payment Transactions
105 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $13.86 | General |
| Category: Immunology | ||||||
| 11/07/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $19.56 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/05/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $19.96 | General |
| Category: IMMUNOLOGY | ||||||
| 08/22/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $17.02 | General |
| Category: Immunology | ||||||
| 08/01/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $14.68 | General |
| Category: IMMUNOLOGY | ||||||
| 07/11/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $15.23 | General |
| Category: Immunology | ||||||
| 06/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $24.67 | General |
| Category: Gastroenterology | ||||||
| 06/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.84 | General |
| Category: Gastroenterology | ||||||
| 06/06/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $14.09 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/03/2024 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $16.61 | General |
| Category: ENDOCRINOLOGY | ||||||
| 04/04/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $19.06 | General |
| Category: ENDOCRINOLOGY | ||||||
| 04/02/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $24.19 | General |
| Category: Gastroenterology | ||||||
| 04/02/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.46 | General |
| Category: Gastroenterology | ||||||
| 03/19/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.57 | General |
| Category: Gastroenterology | ||||||
| 03/04/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $27.56 | General |
| Category: NEUROLOGY | ||||||
| 02/02/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $17.97 | General |
| Category: IMMUNOLOGY | ||||||
| 01/09/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $14.96 | General |
| Category: IMMUNOLOGY | ||||||
| 12/27/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $24.05 | General |
| Category: Gastroenterology | ||||||
| 12/05/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.36 | General |
| Category: Gastroenterology | ||||||
| 11/15/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $21.41 | General |
| Category: Gastroenterology | ||||||
| 11/02/2023 | AbbVie Inc. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $19.87 | General |
| Category: IMMUNOLOGY | ||||||
| 10/19/2023 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $14.98 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/13/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $18.44 | General |
| Category: Gastroenterology | ||||||
| 09/07/2023 | Janssen Biotech, Inc. | REMICADE (Biological), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $13.86 | General |
| Category: Immunology | ||||||
| 07/10/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $21.95 | General |
| Category: Gastroenterology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 867 | 907 | $659,312 | $94,217 |
| 2022 | 15 | 850 | 903 | $646,264 | $92,057 |
| 2021 | 14 | 873 | 923 | $801,414 | $92,501 |
| 2020 | 16 | 883 | 935 | $588,361 | $91,585 |
Total Patients
3,473
Total Services
3,668
Medicare Billing
$370,360
Procedure Codes
60
All Medicare Procedures & Services
60 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 120 | 120 | $157,405 | $22,296 | 14.2% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 128 | 129 | $142,420 | $13,543 | 9.5% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 150 | 154 | $97,845 | $10,237 | 10.5% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 62 | 62 | $57,226 | $10,196 | 17.8% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 71 | 74 | $29,426 | $6,657 | 22.6% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 46 | 46 | $42,458 | $5,326 | 12.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 70 | 87 | $18,476 | $5,316 | 28.8% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 27 | 27 | $29,814 | $4,141 | 13.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 39 | 43 | $13,299 | $3,761 | 28.3% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 36 | 37 | $20,938 | $2,810 | 13.4% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2023 | 27 | 30 | $21,221 | $2,791 | 13.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 22 | 22 | $10,285 | $2,595 | 25.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 14 | 14 | $8,201 | $1,808 | 22.0% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 38 | 45 | $5,119 | $1,563 | 30.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 17 | 17 | $5,179 | $1,177 | 22.7% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 118 | 120 | $157,405 | $22,427 | 14.2% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 137 | 138 | $152,356 | $11,930 | 7.8% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 139 | 142 | $90,221 | $9,624 | 10.7% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 53 | 55 | $50,765 | $9,054 | 17.8% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 66 | 69 | $27,438 | $6,930 | 25.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 48 | 48 | $22,441 | $5,389 | 24.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 71 | 86 | $18,264 | $5,205 | 28.5% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 40 | 40 | $36,920 | $4,688 | 12.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 41 | 49 | $15,154 | $4,308 | 28.4% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2022 | 33 | 38 | $26,880 | $3,608 | 13.4% |
About Dr. Mark Uhl, M.D
Dr. Mark Uhl, M.D is a Gastroenterology healthcare provider based in Gallatin, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/07/2006. The National Provider Identifier (NPI) number assigned to this provider is 1912979501.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Uhl, M.D has received a total of $1,858 in payments from pharmaceutical and medical device companies, with $305.29 received in 2024. These payments were reported across 105 transactions from 25 companies. The most common payment nature is "Food and Beverage" ($1,858).
As a Medicare-enrolled provider, Uhl has provided services to 3,473 Medicare beneficiaries, totaling 3,668 services with total Medicare billing of $370,360. Data is available for 4 years (2020–2023), covering 60 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Gallatin, TN
- Active Since 02/07/2006
- Last Updated 03/14/2025
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1912979501
Products in Payments
- TRULANCE (Drug) $476.72
- XIFAXAN (Drug) $184.84
- Epclusa (Drug) $102.99
- RINVOQ (Biological) $85.11
- CREON (Drug) $65.31
- SKYRIZI (Biological) $59.28
- GENERAL - ENDOCHOICE (Device) $54.66
- GATTEX (Drug) $48.43
- VOQUEZNA (Drug) $33.65
- Trulance (Drug) $33.50
- JARDIANCE (Drug) $32.76
- OMVOH (Drug) $30.88
- LINZESS (Drug) $29.36
- INSPIRE (Device) $27.56
- REMICADE (Biological) $27.43
- Humira (Biological) $27.03
- Sucraid (Drug) $23.98
- VRAYLAR (Drug) $18.94
- APTIMA (Device) $18.42
- GVOKE PFS (Drug) $18.15
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.